Ownership and insider activity for ICU Medical, Inc. (ICUI): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps.
Price
| Price | $166.39 (closing price, October 28, 2026) |
| Market Cap | $4.2B |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-03 | Sanzone Virginia Ruth | S-Sale | 2,202 | $369K |
| 2026-09-03 | Sanzone Virginia Ruth | S-Sale | 1,238 | $209K |
| 2026-09-03 | Sanzone Virginia Ruth | S-Sale | 724 | $123K |
| 2026-09-03 | Sanzone Virginia Ruth | S-Sale | 692 | $119K |
| 2026-09-01 | Bonnell Brian Michael | S-Sale | 6,381 | $1.1M |
| 2026-08-31 | Bonnell Brian Michael | S-Sale | 1,712 | $293K |
| 2026-08-31 | Bonnell Brian Michael | S-Sale | 1,914 | $329K |
| 2026-08-31 | Bonnell Brian Michael | S-Sale | 4,568 | $792K |
| 2026-08-31 | Bonnell Brian Michael | S-Sale | 1,113 | $194K |
| 2026-08-13 | Woolson Daniel | S-Sale | 5,417 | $982K |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $445.1M | $290.1M | $344.8M | $268.7M | $396.1M | $552.8M | $208.8M | $254.2M | $308.6M | $308.0M |
| Short-term Investments | 0 | $10.1M | $37.3M | $24.0M | $14.7M | $14.4M | $4.2M | $501,000 | 0 | 0 |
| Receivables | $59.1M | $149.1M | $196.4M | $202.2M | $127.8M | $124.8M | $246.9M | $182.1M | $202.7M | $180.5M |
| Inventory | $49.3M | $288.7M | $311.2M | $337.6M | $314.9M | $290.2M | $696.0M | $709.4M | $584.7M | $615.9M |
| Total Current Assets | $569.1M | $864.7M | $927.0M | $882.2M | $914.4M | $1.03B | $1.24B | $1.22B | $1.44B | $1.18B |
| Property, Plant & Equipment | $85.7M | $398.7M | $432.6M | $490.6M | $513.2M | $510.9M | $713.6M | $685.5M | $499.3M | $506.3M |
| Goodwill | $5.6M | $12.4M | $11.2M | $31.2M | $33.0M | $43.4M | $1.45B | $1.47B | $1.43B | $1.50B |
| Intangible Assets | $22.4M | $143.8M | $133.4M | $211.4M | $197.2M | $188.3M | $982.8M | $870.6M | $740.8M | $633.6M |
| Total Assets | $704.7M | $1.50B | $1.59B | $1.69B | $1.76B | $1.88B | $4.52B | $4.38B | $4.20B | $4.05B |
| Accounts Payable | $14.6M | $78.2M | $120.5M | $128.6M | $71.9M | $81.1M | $215.9M | $150.0M | $148.0M | $154.4M |
| Short-term Debt | 0 | 0 | 0 | 0 | $9.3M | 0 | $29.7M | $51.0M | $51.0M | $34.7M |
| Total Current Liabilities | $40.5M | $210.3M | $249.3M | $248.5M | $195.5M | $200.8M | $494.6M | $481.8M | $556.2M | $498.9M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | $1.62B | $1.58B | $1.53B | $1.31B |
| Total Liabilities | $44.5M | $298.7M | $321.7M | $315.1M | $261.4M | $264.7M | $2.43B | $2.26B | $2.24B | $1.93B |
| Retained Earnings | $517.0M | $585.6M | $620.7M | $721.8M | $808.7M | $911.8M | $837.5M | $807.8M | $690.2M | $690.9M |
| Total Equity | $660.2M | $1.20B | $1.26B | $1.38B | $1.50B | $1.62B | $2.09B | $2.12B | $1.97B | $2.12B |
| Total Debt | 0 | 0 | 0 | $36.3M | $52.7M | $45.0M | $1.73B | $1.70B | $1.64B | $1.39B |
| Net Debt | -$445.1M | -$300.1M | -$382.1M | -$256.4M | -$358.1M | -$522.2M | $1.52B | $1.45B | $1.33B | $1.08B |
| Working Capital | $528.6M | $654.4M | $677.7M | $633.7M | $718.9M | $829.0M | $740.6M | $739.4M | $885.8M | $678.6M |
Financial Health
| Debt / Equity | 0.59 |
| Current Ratio | 2.43 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 2.17 |
Profitability
| Return on Equity | 1.41% |
| Return on Invested Capital | -21.74% |
| Return on Assets | 0.76% |
| Gross Margin | 37.56% |
| Operating Margin | 5.04% |
| Net Margin | 1.39% |
Related companies: BDX · BAX · TFX · ISRG · 0R29.L · 0R19.L · RMD · 0KW4.L
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of ICUI: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks